The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden
Abstract Soluble ST2 (sST2) is released in response to vascular congestion, inflammation, and pro-fibrotic stimuli. In heart failure (HF), elevated levels of sST2 are associated with a higher risk of adverse clinical outcomes. Emerging evidence suggests that carbohydrate antigen 125 (CA125) may act...
Saved in:
Main Authors: | Elena Revuelta-López, Rafael de la Espriella, Gema Miñana, Enrique Santas, Sandra Villar, Juan Sanchis, Antoni Bayés-Genís, Julio Núñez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84622-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01) -
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels
by: Jeong Min Song, et al.
Published: (2025-01-01) -
The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing
by: Magdalena Dudek, et al.
Published: (2024-12-01) -
Primary Pelvic Tuberculosis That Mimics Ovarian Cancer: A Case Report
by: Özlem Seçilmiş Kerimoğlu, et al.
Published: (2013-04-01) -
Serum-soluble ST2 as a novel biomarker for COVID-19 severity and mortality: A systematic review and meta-analysis
by: Kacper DZIEDZIC, et al.
Published: (2024-03-01)